Nodular melanoma: Patients' perceptions of presenting features and implications for earlier detection

Journal of the American Academy of Dermatology

Volumn 48, Issue 5, 2003, Pages 694-701

  Chamberlain, Alexander J ^a   Fritschi, Lin ^b   Kelly, John W ^a  

^a ALFRED HOSPITAL   (Australia)

^b UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CANCER DIAGNOSIS; CLINICAL FEATURE; COLOR; DISEASE COURSE; EARLY DIAGNOSIS; HUMAN; MAJOR CLINICAL STUDY; MELANOMA; PATIENT ATTITUDE; PIGMENTATION; PRIORITY JOURNAL; QUESTIONNAIRE; SKIN BIOPSY; THICKNESS;

EID: 0037947388     PISSN: 01909622     EISSN: None     Source Type: Journal    
DOI: 10.1067/mjd.2003.216     Document Type: Article

References (30)

1. MacLennan R, Green AC, McLeod GRC, Martin NG. Increasing incidence of cutaneous melanoma in Queensland, Australia. J Natl Cancer Inst 1992;84:1427-32.
2. Burton RC, Coates MC, Hersey P, et al. An analysis of a melanoma epidemic. Int J Cancer 1993;55:765-70.
3. Dennis LK. Analysis of the melanoma epidemic, both apparent and real: data from the 1973 through 1994 surveillance, epidemiology and end results program registry. Arch Dermatol 1999;135:275-80.
4. MacKie RM, Hole D, Hunter JA, Rankin R, Evans A, McLaren K, et al. Cutaneous malignant melanoma in Scotland: incidence, survival, and mortality, 1979-94. BMJ 1997;315:1117-21.
5. Lipsker DM, Hedelin G, Heid E, Grosshans EM, Cribier B. Striking increase of thin melanomas contrasts with stable incidence of thick melanomas. Arch Dermatol 1999;135:1451-6.
6. Melia J, Cooper EJ, Frost T, Graham-Brown R, Hunter J, Marsden A, et al. Cancer research campaign health education programs to promote the early detection of cutaneous malignant melanoma: II, characteristics and incidence of melanoma. Br J Dermatol 1995;132:414-21.
7. Australian Institute of Health and Welfare and the Australasian Association of Cancer Registries. Cancer in Australia 1997: incidence and mortality data for 1997 and selected data for 1998 and 1999. Canberra: Australian Institute of Health and Welfare; 2001. AIHW Cat. No. CAN-15.
8. Chamberlain AJ, Fritschi L, Giles GG, Dowling JP, Kelly JW. Nodular type and older age are the most significant associations of thick melanoma in Victoria, Australia. Arch Dermatol 2002;138:609-14.
9. Kelly JW. Melanoma in the elderly-a neglected public health challenge [editorial]. Med J Aust 1999;169:403-4.
10. Clark WH Jr, From L, Bernardino EA, Mihm MC. The histogenesis and biologic behavior of primary malignant melanomas of the skin. Cancer Res 1969;29:705-26.
11. Mackie RM. Malignant melanoma: clinical variants and prognostic indicators. Clin Exp Dermatol 2000;25:471-5.
12. Porras BH, Cockerell CJ. Cutaneous malignant melanoma: classification and clinical diagnosis. Semin Cutan Med Surg 1997;16:88-96.
13. Brown TJ, Nelson BR. Malignant melanoma: a clinical review. Cutis 1999;63:275-84.
14. McGovern VJ, Cochran AJ, Van Der Esch EP, Little JH, MacLennan R. The classification of malignant melanoma, its histological reporting and registration: a revision of the 1972 Sydney classification. Pathology 1986;18:12-21.
15. Cutler K, Chu P, Levin M, Wallack M, Don PC, Weinberg JM. Pedunculated malignant melanoma. Dermatol Surg 2000;26:127-9.
16. Du Vivier AWP, Williams HC, Brett JV, Higgins EM. How do malignant melanomas present and does this correlate with the seven-point check-list? Clin Exp Dermatol 1991;16:344-7.
17. Mackie RM. Clinical recognition of early invasive malignant melanoma. BMJ 1990;301:1005-6.
18. Brandberg Y, Hansson J, Bergenmar M. Detection of nodular and superficial spreading melanoma ≤2mm-an interview study. Eur J Cancer Prev 2002;11:49-55.
19. Koh HK, Miller DR, Geller AC, Clapp RW, Mercer MB, Lew RA. Who discovers melanoma? J Am Acad Dermatol 1992;26:914-9.
20. Brady MS, Oliviera SA, Christos PJ, Berwick M, Coit DG, Katz J, et al. Patterns of detection in patients with cutaneous melanoma. Cancer 2000;89:342-7.
21. Temoshok L, Diclemente RJ, Sweet DM, Blois MS, Sagebiel RW. Factors related to patient delay in seeking medical attention for cutaneous malignant melanoma. Cancer 1984;54:3048-53.
22. Richard MA, Grob JJ, Avril MF, Delaunay M, Thirion X, Wolkenstein P, et al. Melanoma and tumor thickness: challenges of early diagnosis. Arch Dermatol 1999;135:269-74.
23. Sondergaard K. Biologic behavior of cutaneous malignant melanomas. Pathology 1985;17:255-7.
24. Bergenmar M, Ringborg U, Mansson Brahme E, Brandberg Y. Nodular histogenetic type-the most significant factor for thick melanoma: implications for prevention. Melanoma Res 1998;8:403-11.
25. Binder M, Steiner A, Mossbacher U, Hunegnaw M, Wolff K, Pehamberger H. Quantification of vascularity in nodular melanoma and Spitz's naevus. J Cutan Pathol 1997;24:272-7.
26. Pehamberger H, Honigsmann, Wolff K. Dysplastic naevus syndrome with multiple primary amelanotic melanoma in oculocutaneous albinism. J Am Acad Dermatol 1984;11:731-5.
27. Ihn H, Nakamura K, Abe M, Furue M, Takehara K, Nakagawa H, et al. Amelanotic metastatic melanoma in a patient with oculocutaneous albinism. J Am Acad Dermatol 1993;28:895-900.
28. Straume O, Akslen LA. Prognostic importance of tumor diameter in nodular melanomas [letter]. Ann Plast Surg 1997;5:500-51.
29. Jelfs P, Giles G, Shugg D, Coates M, Durling G, Fitzgerald P, et al. Cutaneous malignant melanoma in Australia, 1989. Med J Aust 1994;161:182-7.
30. Weinstock MA. Early detection of melanoma. JAMA 2000;284:886-9.